Alicia Levey

Alicia Levey is a San Francisco-based Investment Professional.

Alicia leverages her background in biopharma and oncology at Versant to help talented entrepreneurs transition cutting edge technology into value-generating business.

Alicia earned a PhD in Cancer Biology from the Stanford University School of Medicine.

Prior to Stanford, she graduated Summa Cum Laude with dual degrees in Molecular Biology and Biochemistry from the University of Colorado at Boulder where she was a Boettcher Scholar.

While at Stanford, Alicia focused on the development of novel protease inhibitors and protease activity based probes for diagnostic imaging applications.

After her time at Stanford, Alicia worked as a consultant and, later, as a Project Leader in The Boston Consulting Group’s San Francisco office. While at BCG, she focused primarily on biopharma and global health.

Major engagements included working to integrate the oncology portfolios of two major biopharmaceutical companies, and working to develop a new drug and vaccine discovery strategy for a global health foundation. Alicia has authored several peer reviewed scientific publications and her inventions are covered in two US patents.

Alicia Levey is the CBO and SVP at Pionyr Immunotherapeutics, based in United States, North America. With a background in Biotechnology, Alicia Levey has a rich history of leadership and innovation.Alicia Levey studied Ph.D Chemical Biology at Stanford University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.